Cephalosporin API manufacturing plant manufactures a range of oral and sterile Cephalosporin APIs and caters to the developed markets like US, Europe and Japan.
The closure notice has been issued by the Tamil Nadu Pollution Control Board (TNPCB).
Last month, the company has received the US Food and Drug Administration (FDA) approval for following inspection.
In connection with the receiving of the closure notice, the company has assured the regulatory authority to resolve the issues immediately.